Clinical Trial Results:
A 13-week, multicenter, randomized, double-blind, doubledummy,
placebo-controlled, parallel group trial of
lumiracoxib (COX189) 100 mg o.d. in patients with primary
hip osteoarthritis using celecoxib (200 mg o.d.) as a
positive control
Summary
|
|
EudraCT number |
2005-002772-14 |
Trial protocol |
GB DE IT |
Global completion date |
19 Oct 2006
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
28 Aug 2016
|
First version publication date |
28 Aug 2016
|
Other versions |
|
Summary report(s) |
CCOX189A2367.CTR.9Aug2016 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.